Lyophilisation

Lyophilisation, commonly known as freeze-drying, plays a pivotal role in the field of biopharmaceutics, revolutionizing the preservation of sensitive biological materials. This sophisticated process involves freezing a substance and then removing the frozen solvent through sublimation, resulting in a stable, dry product with an extended shelf life.

In biopharmaceutics, lyophilisation is instrumental in preserving the integrity of delicate biomolecules such as proteins, enzymes, and vaccines. This method mitigates the risks of degradation and maintains the bioactivity of these substances, ensuring their efficacy upon reconstitution. The versatility of lyophilisation makes it an indispensable tool in pharmaceuticals, allowing for the development of injectable drugs, oral tablets, and other dosage forms.

Beyond stability, lyophilisation addresses challenges associated with transportation and storage, particularly for biopharmaceuticals that require stringent temperature control. This process facilitates the creation of lightweight, transportable formulations without compromising the therapeutic potential of the drug.

Committee Members
Speaker at Drug Delivery Events - Vladlen Slepak

Vladlen Slepak

University of Miami Miller School of Medicine, United States
Speaker at Drug Delivery Events - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Huiqin Yang

Huiqin Yang

ICON Clinical Research Ltd, United Kingdom

Submit your abstract Today

Watsapp